Literature DB >> 26940204

The diversity of the structure and genomic integration sites of HTLV-1 provirus in MT-2 cell lines.

Yuuki Hashikura1, Kazumi Umeki1, Kunihiko Umekita1, Hajime Nomura1, Ikuo Yamamoto1, Hiroo Hasegawa2, Katsunori Yanagihara2, Akihiko Okayama3.   

Abstract

A human T-lymphotropic virus Type 1 (HTLV-1) positive cell line, MT-2, derived from human cord leukocytes co-culturing with adult T cell leukemia/lymphoma (ATL) cells is commonly used in HTLV-1 research; however, the details of provirus integrated in MT-2 genome have not yet been characterized. In this study, five types of HTLV-1 proviral sequences were detected in 11 different sites of the genome in a reference MT-2 cell line. The five types of HTLV-1 proviral sequences were one complete proviral genome, two types of proviruses with deletion of large internal viral sequences (5.3 and 3.9 kB), one provirus with a large deletion (6.2 kB) from 5'LTR to position 6257, and one provirus of LTR only. The provirus with identical deletion of large internal viral sequence (5.3 kB) was found to be integrated into six different sites (chromosomes). A complete provirus and three of four types of defective provirus were consistently detected in two other MT-2 cell lines cultured in different laboratories. Not only Tax/Rex RNA and HBZ RNA, but also the transcriptional product for a specific defective provirus, were detectable in all three MT-2 cell lines. Because it has been reported that defective provirus is frequently detected in ATL cells, these results may be important in understanding the mechanism of HTLV-1 proviral polymorphism, which may be related to leukemogenesis. In addition, the large variation in integrated HTLV-1 proviruses makes it important for researchers to exercise caution in their assessment and interpretation of results using MT-2 cell lines.

Entities:  

Keywords:  Defective virus; HTLV-1; MT-2 cell line

Mesh:

Year:  2016        PMID: 26940204     DOI: 10.1007/s13577-016-0136-8

Source DB:  PubMed          Journal:  Hum Cell        ISSN: 0914-7470            Impact factor:   4.174


  26 in total

1.  Molecular cloning of cDNA encoding gp68 of adult T-cell leukaemia-associated antigen: evidence for expression of the pX IV region of human T-cell leukaemia virus.

Authors:  K Takeuchi; N Kobayashi; S H Nam; N Yamamoto; M Hatanaka
Journal:  J Gen Virol       Date:  1985-08       Impact factor: 3.891

2.  Structural analysis of p28 adult T-cell leukaemia-associated antigen.

Authors:  T Iino; K Takeuchi; S H Nam; H Siomi; H Sabe; N Kobayashi; M Hatanaka
Journal:  J Gen Virol       Date:  1986-07       Impact factor: 3.891

3.  Retroviruses as mutagens: insertion and excision of a nontransforming provirus alter expression of a resident transforming provirus.

Authors:  H E Varmus; N Quintrell; S Ortiz
Journal:  Cell       Date:  1981-07       Impact factor: 41.582

4.  Persistent clonal proliferation of human T-lymphotropic virus type I-infected cells in vivo.

Authors:  K Etoh; S Tamiya; K Yamaguchi; A Okayama; H Tsubouchi; T Ideta; N Mueller; K Takatsuki; M Matsuoka
Journal:  Cancer Res       Date:  1997-11-01       Impact factor: 12.701

5.  HTLV-I basic leucine zipper factor gene mRNA supports proliferation of adult T cell leukemia cells.

Authors:  Yorifumi Satou; Jun-ichirou Yasunaga; Mika Yoshida; Masao Matsuoka
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-09       Impact factor: 11.205

6.  Integration patterns of HTLV-I provirus in relation to the clinical course of ATL: frequent clonal change at crisis from indolent disease.

Authors:  K Tsukasaki; H Tsushima; M Yamamura; T Hata; K Murata; T Maeda; S Atogami; H Sohda; S Momita; S Ideda; S Katamine; Y Yamada; S Kamihira; M Tomonaga
Journal:  Blood       Date:  1997-02-01       Impact factor: 22.113

7.  Proviral loads of human T-lymphotropic virus Type 1 in asymptomatic carriers with different infection routes.

Authors:  Shiro Ueno; Kazumi Umeki; Ichiro Takajo; Yasuhiro Nagatomo; Norio Kusumoto; Kunihiko Umekita; Kazuhiro Morishita; Akihiko Okayama
Journal:  Int J Cancer       Date:  2011-08-29       Impact factor: 7.396

8.  Transformation of human leukocytes by cocultivation with an adult T cell leukemia virus producer cell line.

Authors:  N Yamamoto; M Okada; Y Koyanagi; M Kannagi; Y Hinuma
Journal:  Science       Date:  1982-08-20       Impact factor: 47.728

9.  Preferential selection of human T-cell leukemia virus type 1 provirus lacking the 5' long terminal repeat during oncogenesis.

Authors:  Maki Miyazaki; Jun-Ichirou Yasunaga; Yuko Taniguchi; Sadahiro Tamiya; Tatsutoshi Nakahata; Masao Matsuoka
Journal:  J Virol       Date:  2007-03-07       Impact factor: 5.103

10.  Genomic structure of HTLV (human T-cell leukemia virus): detection of defective genome and its amplification in MT-2 cells.

Authors:  N Kobayashi; H Konishi; H Sabe; K Shigesada; T Noma; T Honjo; M Hatanaka
Journal:  EMBO J       Date:  1984-06       Impact factor: 11.598

View more
  5 in total

1.  Polymorphic Nature of Human T-Cell Leukemia Virus Type 1 Particle Cores as Revealed through Characterization of a Chronically Infected Cell Line.

Authors:  Morgan E Meissner; Luiza M Mendonça; Wei Zhang; Louis M Mansky
Journal:  J Virol       Date:  2017-07-27       Impact factor: 5.103

2.  Infection of defective human T-lymphotropic virus type 1.

Authors:  Yuuki Hashikura; Kazumi Umeki; Kunihiko Umekita; Hajime Nomura; Akiteru Yamada; Ikuo Yamamoto; Hiroo Hasegawa; Katsunori Yanagihara; Akihiko Okayama
Journal:  Hum Cell       Date:  2017-01-09       Impact factor: 4.174

3.  The Tax-Inducible Actin-Bundling Protein Fascin Is Crucial for Release and Cell-to-Cell Transmission of Human T-Cell Leukemia Virus Type 1 (HTLV-1).

Authors:  Christine Gross; Veit Wiesmann; Sebastian Millen; Martina Kalmer; Thomas Wittenberg; Jan Gettemans; Andrea K Thoma-Kress
Journal:  PLoS Pathog       Date:  2016-10-24       Impact factor: 6.823

4.  Downregulation of proinflammatory cytokines in HTLV-1-infected T cells by Resveratrol.

Authors:  Maria Pia Fuggetta; Valentina Bordignon; Andrea Cottarelli; Beatrice Macchi; Caterina Frezza; Paola Cordiali-Fei; Fabrizio Ensoli; Stefania Ciafrè; Francesca Marino-Merlo; Antonio Mastino; Giampietro Ravagnan
Journal:  J Exp Clin Cancer Res       Date:  2016-07-22

5.  Screening for 15 pathogenic viruses in human cell lines registered at the JCRB Cell Bank: characterization of in vitro human cells by viral infection.

Authors:  Setsuko Shioda; Fumio Kasai; Ken Watanabe; Kohei Kawakami; Azusa Ohtani; Masashi Iemura; Midori Ozawa; Akemi Arakawa; Noriko Hirayama; Eiko Kawaguchi; Tomoko Tano; Sayaka Miyata; Motonobu Satoh; Norio Shimizu; Arihiro Kohara
Journal:  R Soc Open Sci       Date:  2018-05-02       Impact factor: 2.963

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.